Carregant...

Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants

The success of targeting kinases in cancer with small molecule inhibitors has been tempered by the emergence of drug-resistant kinase domain mutations. In patients with chronic myeloid leukemia treated with ABL inhibitors, BCR-ABL kinase domain mutations are the principal mechanism of relapse. Certa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Skaggs, Brian J., Gorre, Mercedes E., Ryvkin, Ann, Burgess, Michael R., Xie, Yongming, Han, Yun, Komisopoulou, Evangelia, Brown, Lauren M., Loo, Joseph A., Landaw, Elliot M., Sawyers, Charles L., Graeber, Thomas G.
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2006
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1698443/
https://ncbi.nlm.nih.gov/pubmed/17164333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0609239103
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!